Moreover, concentrations of the MPO–DNA complexes before bariatric surgery were associated with cardiometabolic risk factors, such as proxy measures of obesity, blood pressure (BP), and markers of glucose metabolism, but not with lipids profile. Here, MPO is linked to obesity disorder.